Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic, Wegovy face US Medicare price negotiations
Novo's Ozempic, Wegovy picked for US Medicare price negotiations
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday.
Novo Nordisk stock prices drop after Biden lists Ozempic for price negotiations
Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs for mandatory price negotiations.
Ozempic and Wegovy among drugs on Medicare list getting price cuts
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than $200 billion over a decade.
Novo Nordisk CEO attends crisis talks with Danish PM
Novo Nordisk CEO attends crisis talks with Danish PM amid Donald Trump Greenland threats
Bosses from Fortune 500 Europe companies including Novo Nordisk, Lego, and Carlsberg met with the PM as Trump ups his threats over Greenland.
Novo Nordisk, Other Firms Meet Danish PM to Discuss Trump Tariff Threats
Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group said on Thursday after business leaders, including CEO of obesity drugmaker Novo Nordisk,
Novo, Other Firms Meet Danish Premier Over Trump’s Threats
Danish Prime Minister Mette Frederiksen met with business leaders including the head of Novo Nordisk A/S to discuss potential measures by the incoming Trump administration amid escalating tensions over Greenland.
15h
on MSN
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...
10h
Meet ‘Super’ Ozempic: Higher Dose Semaglutide Leads to Even Greater Weight Loss In Major Trial
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
14h
on MSN
These Stocks Are Moving the Most Today: Apple, Qorvo, Novo Nordisk, SLB, J.B. Hunt, Rivian, Cloudflare, and More
Stocks rallied sharply Friday and the S&P 500 was on pace for its best week since early November.These stocks were making ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
To go dark on Sunday
Cabinet approves Gaza deal
To skip Trump’s inauguration
Opposes Fani Willis' bid
Polar vortex to freeze US
Sign partnership treaty
Senate confirmation hearing
Denied bail in assault case
CA battery storage plant fire
To fill Vance’s Senate seat
Pence advocates for Taiwan
US drops corruption case
Attempted attack sentencing
New Pompeii excavation
Acting legend Plowright dies
Liable for defaming veteran
FTC sues PepsiCo
Navalny lawyers sentenced
Texas abortion pill ruling
Khan gets 14-year jail term
Commutes more sentences
Apple halts AI news alerts
NHTSA probing GM vehicles
Bitcoin soars past $100K
Calls for stronger sanctions
To negotiate drug prices
Related topics
Medicare
Wegovy
Feedback